Martin Barrett and Rostislav Shevchenko from Pharmidex are at #EUROTOX24!
September 9, 2024
Say "Hej!" if you see them.
If you'd like to discuss how Pharmidex can provide toxicology support (GLP/non-GLP) for your projects, arrange a meeting by connecting on LinkedIn or by emailing [email protected].

#copenhagen #eurotox #pharmidex #contractresearchorganisation #cro #GLP #toxicology
#drugdevelopment #drugdiscovery #preclinical #conference #meeting

We’re delighted to welcome Gabrielle Georgiou and Dr. Mohammed Ahmad from the University of Hertfordshire as they begin their first experience in a scientific CRO environment here at Pharmidex ! This partnership is an exciting step in fostering early-career scientific talent by offering hands-on exposure to real-world drug discovery and preclinical research. A big thank you to the University of Hertfordshire for partnering with us to support the next generation of innovators. We’re proud to play a role in shaping future leaders in science through meaningful, practical learning opportunities. 👩🔬 👨🔬 Welcome to the team, Gabrielle and Mohammed!

At Pharmidex , we offer Brief Access Taste Aversion (BATA) testing, which is a behavioural assay that quantifies how test subjects respond to different compounds or formulations by measuring lick response and aversion. This helps identify: ✅ Bitter-tasting APIs ✅ Unpalatable excipients ✅ The success of taste-masking strategies ✅ Formulation-dependent compliance risks Get in touch if you’re developing oral formulations, paediatric drugs, or repurposing bitter APIs, this could be the data your IND package needs.